Our company focuses on R&D of anti-cancer drugs, and is engaged in developing novel anticancer hypoxia activated prodrugs, small molecular targeted anticancer drugs and cell signal pathway inhibitors. Since its inception, we have been paying attention to the protection of intellectual properties, and declaring inventive patent actively. Up to now, we have been awarded a number of inventive patents, and are looking forward to sharing these intellectual properties with institutions and companies who are committed to this research area.
|
Application or Invention No.
|
Name of Invention patents
|
|
201210038110.8
|
Synthesis methods of molecular targeted anticancer drug Crizotinib
|
|
201210211142.3
|
Development of anticancer o-nitro aromatic methoxy hypoxia-activated prodrugs based on Camptothecin
|
|
201210211145.7
|
Dvelopment of anticancer nitroaryl methoxy hypoxia-activated prodrugs based on Camptothecin
|
|
201210211151.2
|
Development of anticancer nitro aromatic methoxy hypoxia-activated prodrugs based on Camptothecin
|
|
201210334540.4
|
Synthesis of 3 - chloro-5 - amino pyridazine as medicinal and pesticide intermediates
|
|
